Aflibercept for long-term treatment of diabetic macular edema and proliferative diabetic retinopathy: a meta-analysis

Aflibercept for long-term treatment of diabetic macular edema and proliferative diabetic retinopathy: a meta-analysis

PurposeThis meta-analysis compared the long-term (12 months or 24 months) efficacy and safety of intravitreal aflibercept injection (IAI) for diabetic macular edema (DME) and proliferative diabetic retinopathy (PDR).MethodsWe selected 16 randomized controlled trials (RCTs) performed after 2015 that...

Full description

Bibliographic Details
Main Authors: Xiao Xie, Chao Lian, Zhiping Zhang, Meng Feng, Wenqi Wang, Xiaomeng Yuan, Yanmei Shi, Tingting Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-05-01
Series:Frontiers in Endocrinology
Subjects:
diabetic macular edema
proliferative diabetic retinopathy
aflibercept
meta-analysis
anti-vascular endothelial growth factor
focal/grid laser photocoagulation
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2023.1144422/full

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2023.1144422/full

Similar Items